Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

被引:24
|
作者
Charil, Arnaud [1 ]
Shcherbinin, Sergey [1 ]
Southekal, Sudeepti [5 ]
Devous, Michael D. [5 ]
Mintun, Mark [1 ,5 ]
Murray, Melissa E. [4 ]
Miller, Bradley B. [1 ]
Schwarz, Adam J. [1 ,2 ,3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[3] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
Hippocampal sparing; limbic predominant; subtype; tau; NEUROPATHOLOGICALLY DEFINED SUBTYPES; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ATROPHY; F-18-AV-1451; PATHOLOGY; RECOMMENDATIONS; PATTERNS;
D O I
10.3233/JAD-190264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
At autopsy, individuals with Alzheimer's disease (AD) exhibit heterogeneity in the distribution of neurofibrillary tangles in neocortical and hippocampal regions. Subtypes of AD, defined using an algorithm based on the relative number of tangle counts in these regions, have been proposed-hippocampal sparing (relative sparing of the hippocampus but high cortical load), limbic predominant (high hippocampal load but lower load in association cortices), and typical (balanced neurofibrillary tangles counts in the hippocampus and association cortices) AD-and shown to be associated with distinct antemortem clinical phenotypes. The ability to distinguish these AD subtypes from the more typical tau signature in vivo could have important implications for clinical research. Flortaucipir positron emission tomography (PET) images acquired from 45 amyloid-positive participants, defined clinically as mild cognitive impairment or AD, aged 50-92 years, 56% female, and estimated to be Braak V-VI based on their PET pattern of tau pathology, were studied. By translating the neuropathologic algorithm to flortaucipir PET scans, patterns of tau pathology consistent with autopsy findings, and with a similar prevalence, were identified in vivo. 6/45 (13%) participants were identified as hippocampal sparing and 6/45 (13%) as limbic predominant AD subtypes. Hippocampal sparing participants were significantly younger than those assigned to the other two subtypes. Worse performance on delayed recall was associated with increased hippocampal tau signal, and worse performance on the trail making test B-A was associated with lower values of the hippocampus to cortex ratio. Prospective studies can further validate the flortaucipir SUVR cut-points and the phenotype of the corresponding AD subtypes.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [21] In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease
    Villemagne, Victor L.
    Furumoto, Shozo
    Fodero-Tavoletti, Michelle T.
    Mulligan, Rachel S.
    Hodges, John
    Harada, Ryuichi
    Yates, Paul
    Piguet, Olivier
    Pejoska, Svetlana
    Dore, Vincent
    Yanai, Kazuhiko
    Masters, Colin L.
    Kudo, Yukitsuka
    Rowe, Christopher C.
    Okamura, Nobuyuki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 816 - 826
  • [22] Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer's disease pathology: a clinicopathological study
    Pontecorvo, Michael J.
    Keene, C. Dirk
    Beach, Thomas G.
    Montine, Thomas J.
    Arora, Anupa K.
    Devous, Michael D., Sr.
    Navitsky, Michael
    Kennedy, Ian
    Joshi, Abhinay D.
    Lu, Ming
    Serrano, Geidy E.
    Sue, Lucia I.
    Intorcia, Anthony J.
    Rose, Shannon E.
    Wilson, Angela
    Hellstern, Leanne
    Coleman, Natalie
    Flitter, Matthew
    Aldea, Patricia
    Fleisher, Adam S.
    Mintun, Mark A.
    Siderowf, Andrew
    EJNMMI RESEARCH, 2020, 10 (01)
  • [23] Tau-PET-based biological staging of Alzheimer's disease in vivo
    Therriault, Joseph
    Rosa-Neto, Pedro
    NATURE AGING, 2022, 2 (06): : 471 - 472
  • [25] Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum
    Timmers, Tessa
    Ossenkoppele, Rik
    Wolters, Emma E.
    Verfaillie, Sander C. J.
    Visser, Denise
    Golla, Sandeep S., V
    Barkhof, Frederik
    Scheltens, Philip
    Boellaard, Ronald
    van der Flier, Wiesje M.
    van Berckel, Bart N. M.
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1)
  • [26] Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
    Michael J. Pontecorvo
    C. Dirk Keene
    Thomas G. Beach
    Thomas J. Montine
    Anupa K. Arora
    Michael D. Devous
    Michael Navitsky
    Ian Kennedy
    Abhinay D. Joshi
    Ming Lu
    Geidy E. Serrano
    Lucia I. Sue
    Anthony J. Intorcia
    Shannon E. Rose
    Angela Wilson
    Leanne Hellstern
    Natalie Coleman
    Matthew Flitter
    Patricia Aldea
    Adam S. Fleisher
    Mark A. Mintun
    Andrew Siderowf
    EJNMMI Research, 10
  • [27] Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
    Konstantinos Chiotis
    Laure Saint-Aubert
    Irina Savitcheva
    Vesna Jelic
    Pia Andersen
    My Jonasson
    Jonas Eriksson
    Mark Lubberink
    Ove Almkvist
    Anders Wall
    Gunnar Antoni
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1686 - 1699
  • [28] Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
    Chiotis, Konstantinos
    Saint-Aubert, Laure
    Savitcheva, Irina
    Jelic, Vesna
    Andersen, Pia
    Jonasson, My
    Eriksson, Jonas
    Lubberink, Mark
    Almkvist, Ove
    Wall, Anders
    Antoni, Gunnar
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1686 - 1699
  • [29] Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
    Tessa Timmers
    Rik Ossenkoppele
    Emma E. Wolters
    Sander C. J. Verfaillie
    Denise Visser
    Sandeep S. V. Golla
    Frederik Barkhof
    Philip Scheltens
    Ronald Boellaard
    Wiesje M. van der Flier
    Bart N. M. van Berckel
    Alzheimer's Research & Therapy, 11
  • [30] Tau PET Imaging Predicts Cognition in Atypical Variants of Alzheimer's Disease
    Phillips, Jeffrey
    Das, Sandhitsu
    McMillan, Corey
    Irwin, David
    Nasrallah, Ilya
    Wolk, David
    Grossman, Murray
    NEUROLOGY, 2017, 88